Literature DB >> 10654819

The role of osteoprogenitors in vascular calcification.

M G Jakoby1, C F Semenkovich.   

Abstract

Calcification is a component of vascular disease that usually occurs in concert with atheroma formation but through distinct pathophysiological processes. Vessel wall osteoprogenitor cells known as calcifying vascular cells can form bone matrix proteins and calcified nodules, analogous to osteoblastic differentiation in bone. These cells have been isolated from the tunica media of bovine and human arteries, and both in-vitro tissue culture models and mouse models of vascular calcification have been established. Studies of the effects of diabetes mellitus, hyperlipidemia, estrogens and glucocorticoids on calcifying vascular cell function provide insight into the relationship between common human disease states and vascular calcification.

Entities:  

Mesh:

Year:  2000        PMID: 10654819     DOI: 10.1097/00041552-200001000-00003

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

1.  Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia.

Authors:  Emily J Tomayko; Hae R Chung; Kenneth R Wilund
Journal:  J Bone Miner Metab       Date:  2011-06-03       Impact factor: 2.626

Review 2.  Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease.

Authors:  János Nemcsik; István Kiss; András Tislér
Journal:  World J Nephrol       Date:  2012-02-06

3.  Optical imaging of hydroxyapatite in the calcified vasculature of transgenic animals.

Authors:  Atif Zaheer; Monzur Murshed; Alec M De Grand; Timothy G Morgan; Gerard Karsenty; John V Frangioni
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-16       Impact factor: 8.311

4.  Vascular calcification score on plain radiographs of the feet as a predictor of peripheral arterial disease in patients with chronic kidney disease.

Authors:  Won Suk An; Young Ki Son; Seong-Eun Kim; Ki-Hyun Kim; Seong Kuk Yoon; Hae-Rahn Bae; Seo-Hee Rha
Journal:  Int Urol Nephrol       Date:  2009-12-30       Impact factor: 2.370

5.  The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control.

Authors:  Mario Cozzolino; Florjan Mehmeti; Paola Ciceri; Elisa Volpi; Andrea Stucchi; Irene Brenna; Daniele Cusi
Journal:  Int J Nephrol       Date:  2011-03-29

Review 6.  Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective.

Authors:  Yogesh Nv Reddy; Varun Sundaram; Georgi Abraham; Prethivee Nagarajan; Yuvaram Nv Reddy
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-23

7.  Where is the link between mineral bone markers and cardiovascular disease in CKD?

Authors:  Mario Cozzolino; Marzia Pasquali
Journal:  Clin Kidney J       Date:  2015-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.